Scale Biosciences, Inc.
- UEI
- CF3JS2A7L3Z3
- CAGE
- 9GNW1
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Expired
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Website
- scale.bio
- Founded
- 2020
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $151,435 |
Contract awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| BPS Bioscience Inc. | San Diego, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Bruker Cellular Analysis, Inc. | Emeryville, CA | 334516 Analytical Laboratory Instrument Manufacturing |
| Ampseq LLC | Gaithersburg, MD | 541380 Testing Laboratories and Services |
| Dotquant LLC | Shoreline, WA | — |
| Medgenome Inc. | Foster City, CA | 621511 Medical Laboratories |
About the company
Scale Biosciences, Inc. is a for-profit biotechnology company located in San Diego, California, specializing in advanced single-cell genomics technologies and research reagents. Registered in SAM.gov since January 2023, the company provides specialized scientific research products focused on cellular analysis techniques, with a particular emphasis on single-cell methylation and RNA kit technologies. The organization's core competencies appear centered on developing proprietary molecular biology reagents and kits that support advanced genomic and epigenomic research methodologies.
The company has secured multiple federal contract awards from prominent National Institutes of Health (NIH) agencies, specifically the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute of Allergy and Infectious Diseases (NIAID). These contracts, ranging from $10,650 to $115,835, have been predominantly for the procurement of specialized research kits, including single-cell methylation reagents and RNA kits. The contract awards demonstrate a pattern of sole-source and small business set-aside procurement strategies, indicating Scale Biosciences' unique technological capabilities. The contracts have varying performance periods, with the most recent award from NIAAA being a sole-source purchase order for single-cell methylation reagents valued at $115,835, running from August 15, 2025 to August 14, 2026. These federal contract awards suggest the company plays a specialized role in supporting advanced scientific research, particularly in areas related to infectious diseases and alcohol abuse research.
Quick answers
Is Scale Biosciences, Inc. registered in SAM.gov?
Scale Biosciences, Inc.'s SAM.gov registration expired on January 28, 2026.
What is Scale Biosciences, Inc.'s CAGE code?
Scale Biosciences, Inc.'s CAGE code is 9GNW1, and its Unique Entity ID (UEI) is CF3JS2A7L3Z3.
How much has Scale Biosciences, Inc. received in federal contracts?
Federal contracts obligated $151,435 to Scale Biosciences, Inc. in fiscal year 2025.
How does Scale Biosciences, Inc. rank among federal contractors?
Scale Biosciences, Inc. ranked #75 in NAICS 325414 in FY2025.
What is Scale Biosciences, Inc.'s most recent federal award?
Scale Biosciences, Inc.'s most recent federal contract award is Niaaa: supply: single cell methylation - severable (75N94025P00436), from National Institute of Child Health and Human Development (NIH), on August 15, 2025.
On GovTribe
See Scale Biosciences, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors